Vepesid Injection

Molecule: Etoposide

Strength: 50 mg

Quantity: 1 Vial

Form: Injection

Packaging Type: Vial

Manufacturer/Marketed By: Bristol Myers Squibb

Country of Origin: U.K

Description

Etoposide injection, also referred to as VP-16 or Vepesid, is utilized alongside various cancer medications to manage testicular and small-cell lung cancer. It is also employed at times for the treatment of other cancer types in both men and women. Classified under antineoplastic agents, Etoposide operates by impeding the cancer cells' growth, leading to their eventual eradication. While the precise mechanism of Etoposide against cancer remains unknown, its impact on normal body cells may result in additional effects. Specific effects might be severe and necessitate immediate reporting to a medical professional, whereas others, such as hair loss, although not critical, could be distressing.